drugset / Trial / NCT06584812

Study to Assess Pharmacokinetics, Pharmacodynamics and Safety of Tiprogrel in Healthy Subjects

NCT06584812

NaSequentialOpen-labelBasic science

Summary

This study is designed to evaluate the pharmacokinetics, pharmacodynamics and safety in healthy subjects with multiple administration of Tiprogrel.

Timeline

Start
2024-09-09
Primary completion
2024-12-05
Completion
2024-12-17

Drugs

EvaluationDrugModalityDoseRoute
Subject Clopidogrel Small molecule
Subject Ticagrelor Small molecule
Subject Tiprogrel Unknown Oral